Wangting Xu

Affiliated Sir Run Run Shaw Hospital
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation.

Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation.

Journal: Biomaterials

Published: November 15, 2025

Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches.

Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches.

Journal: Biomarker research

Published: September 18, 2025

Gut-Brain-Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors.

Gut-Brain-Microbiome Axis in the Regulation of Cancer Immune Escape and Immunotherapy in Tumors.

Journal: Research (Washington, D.C.)

Published: June 18, 2025

Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies.

Ferroptosis in Pulmonary Disease and Lung Cancer: Molecular Mechanisms, Crosstalk Regulation, and Therapeutic Strategies.

Journal: MedComm

Published: August 23, 2024

Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.

Targeting SLC7A11/xCT improves radiofrequency ablation efficacy of HCC by dendritic cells mediated anti-tumor immune response.

Journal: iMeta

Published: August 22, 2024

NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6Clow Monocytes/Macrophages Differentiation to Accelerate Thrombolysis.

NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6Clow Monocytes/Macrophages Differentiation to Accelerate Thrombolysis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 27, 2023

Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer.

Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer.

Journal: Cancer letters

Published: September 22, 2022

SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis.

SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis.

Journal: The Journal of clinical investigation

Published: June 20, 2022

Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.

Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death.

Journal: Clinical immunology (Orlando, Fla.)

Published: July 23, 2021

Gremlin2 Activates Fibroblasts to Promote Pulmonary Fibrosis Through the Bone Morphogenic Protein Pathway.

Gremlin2 Activates Fibroblasts to Promote Pulmonary Fibrosis Through the Bone Morphogenic Protein Pathway.

Journal: Frontiers in molecular biosciences

Published: March 20, 2021

Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.

Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.

Journal: Nature communications

Published: December 08, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026